In this episode, Nathan Latka interviews the CEO of Reveleer, who discusses the company's remarkable transition from $25 million to $50 million in annual revenue through AI-powered solutions focused on value-based care in healthcare. The conversation emphasizes the importance of strategic mergers and acquisitions, capital stewardship, and innovative product development in navigating challenges like COVID-19. Reveleer's approach combines advanced machine learning and strong customer relationships, aiming for a billion-dollar valuation and highlighting the complexities of healthcare SaaS.